{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:53:52Z","timestamp":1794369232218,"version":"4.9.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T00:00:00Z","timestamp":1586476800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T00:00:00Z","timestamp":1586476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Short supraventricular tachycardias with atrial fibrillation (AF) characteristics are associated with an increased risk of developing AF over time. The aim of this study is to determine if presence of very short-lasting episodes of AF-like activity (micro-AF) can also be used as a marker of undiagnosed silent atrial fibrillation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In the STROKESTOP II study, a Swedish mass screening study for AF among 75- and 76-year-olds, participants with NT-proBNP \u2265125\u2009ng\/L performed intermittent ECG recordings 30\u2009s, four times daily for 2 weeks. Participants with micro-AF (sudden onset of irregular tachycardia with episodes of \u22655 consecutive supraventricular beats and total absence of p-waves, lasting less than 30\u2009s) were invited to undergo extended AF screening using continuous event recording for 2 weeks. A control group of individuals without micro-AF was examined using the same ECG modalities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Out of 3763 participants in STROKESTOP II who had elevated NT-proBNP levels and were free of AF,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009221 (6%) had micro-AF. The majority of participants with micro-AF (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009196) accepted further investigation with continuous ECG monitoring which showed presence of AF in 26 of them. In the control group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009250), continuous monitoring detected 7 new AF cases. Thus, AF was significantly more common in the micro AF group (13%) compared to the control group (3%),\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Presence of short-lasting episodes of AF-like activity (micro-AF) indicates increased likelihood for undetected AF. Continuous screening therefore seems recommendable if a finding of AF would change clinical management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trail registration<\/jats:title>\n                    <jats:p>ClinicalTrials.gov, identifier: NCT02743416, registered April 19, 2016.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-020-01453-w","type":"journal-article","created":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T10:02:52Z","timestamp":1586512972000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Brief episodes of rapid irregular atrial activity (micro-AF) are a risk marker for atrial fibrillation: a prospective cohort study"],"prefix":"10.1186","volume":"20","author":[{"given":"Tove","family":"Fredriksson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin Kemp","family":"Gudmundsdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viveka","family":"Frykman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif","family":"Friberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faris","family":"Al-Khalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Engdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Svennberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,10]]},"reference":[{"key":"1453_CR1","unstructured":"Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, et al. ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. 2016;18(11):1609\u201378."},{"issue":"8","key":"1453_CR2","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","volume":"22","author":"PA Wolf","year":"1991","unstructured":"Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke. 1991;22(8):983\u20138.","journal-title":"Stroke"},{"issue":"11","key":"1453_CR3","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1001\/jamaneurol.2015.2161","volume":"72","author":"RF de Bruijn","year":"2015","unstructured":"de Bruijn RF, Heeringa J, Wolters FJ, Franco OH, Stricker BH, Hofman A, Koudstaal PJ, Ikram MA. Association between atrial fibrillation and dementia in the general population. JAMA neurology. 2015;72(11):1288\u201394.","journal-title":"JAMA neurology"},{"issue":"10","key":"1453_CR4","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","volume":"98","author":"EJ Benjamin","year":"1998","unstructured":"Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham heart study. Circulation. 1998;98(10):946\u201352.","journal-title":"Circulation"},{"issue":"8","key":"1453_CR5","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/eurjhf\/hft041","volume":"15","author":"RB Schnabel","year":"2013","unstructured":"Schnabel RB, Rienstra M, Sullivan LM, Sun JX, Moser CB, Levy D, Pencina MJ, Fontes JD, Magnani JW, McManus DD, et al. Risk assessment for incident heart failure in individuals with atrial fibrillation. Eur J Heart Fail. 2013;15(8):843\u20139.","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"1453_CR6","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1093\/eurheartj\/ehx579","volume":"39","author":"L Friberg","year":"2018","unstructured":"Friberg L, Rosenqvist M. Less dementia with oral anticoagulation in atrial fibrillation. Eur Heart J. 2018;39(6):453\u201360.","journal-title":"Eur Heart J"},{"issue":"7","key":"1453_CR7","doi-asserted-by":"publisher","first-page":"492","DOI":"10.7326\/0003-4819-131-7-199910050-00003","volume":"131","author":"RG Hart","year":"1999","unstructured":"Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med. 1999;131(7):492\u2013501.","journal-title":"Ann Intern Med"},{"issue":"17","key":"1453_CR8","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1161\/CIRCULATIONAHA.109.874982","volume":"121","author":"Z Binici","year":"2010","unstructured":"Binici Z, Intzilakis T, Nielsen OW, Kober L, Sajadieh A. Excessive supraventricular ectopic activity and increased risk of atrial fibrillation and stroke. Circulation. 2010;121(17):1904\u201311.","journal-title":"Circulation"},{"issue":"9","key":"1453_CR9","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1016\/j.hrthm.2015.04.042","volume":"12","author":"LS Johnson","year":"2015","unstructured":"Johnson LS, Juhlin T, Juul-Moller S, Hedblad B, Nilsson PM, Engstrom G. A prospective study of supraventricular activity and incidence of atrial fibrillation. Heart Rhythm. 2015;12(9):1898\u2013904.","journal-title":"Heart Rhythm"},{"issue":"12","key":"1453_CR10","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1161\/01.STR.31.12.2925","volume":"31","author":"G Engstrom","year":"2000","unstructured":"Engstrom G, Hedblad B, Juul-Moller S, Tyden P, Janzon L. Cardiac arrhythmias and stroke: increased risk in men with high frequency of atrial ectopic beats. Stroke. 2000;31(12):2925\u20139.","journal-title":"Stroke"},{"issue":"3","key":"1453_CR11","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jacc.2015.05.018","volume":"66","author":"BS Larsen","year":"2015","unstructured":"Larsen BS, Kumarathurai P, Falkenberg J, Nielsen OW, Sajadieh A. Excessive atrial Ectopy and short atrial runs increase the risk of stroke beyond incident atrial fibrillation. J Am Coll Cardiol. 2015;66(3):232\u201341.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"1453_CR12","doi-asserted-by":"publisher","first-page":"721","DOI":"10.7326\/0003-4819-159-11-201312030-00004","volume":"159","author":"TA Dewland","year":"2013","unstructured":"Dewland TA, Vittinghoff E, Mandyam MC, Heckbert SR, Siscovick DS, Stein PK, Psaty BM, Sotoodehnia N, Gottdiener JS, Marcus GM. Atrial ectopy as a predictor of incident atrial fibrillation: a cohort study. Ann Intern Med. 2013;159(11):721\u20138.","journal-title":"Ann Intern Med"},{"issue":"3","key":"1453_CR13","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/eurheartj\/ehu407","volume":"36","author":"N Murakoshi","year":"2015","unstructured":"Murakoshi N, Xu D, Sairenchi T, Igarashi M, Irie F, Tomizawa T, Tada H, Sekiguchi Y, Yamagishi K, Iso H, et al. Prognostic impact of supraventricular premature complexes in community-based health checkups: the Ibaraki prefectural health study. Eur Heart J. 2015;36(3):170\u20138.","journal-title":"Eur Heart J"},{"issue":"3","key":"1453_CR14","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1161\/STROKEAHA.113.003788","volume":"45","author":"S Kochhauser","year":"2014","unstructured":"Kochhauser S, Dechering DG, Dittrich R, Reinke F, Ritter MA, Ramtin S, Duning T, Frommeyer G, Eckardt L. Supraventricular premature beats and short atrial runs predict atrial fibrillation in continuously monitored patients with cryptogenic stroke. Stroke. 2014;45(3):884\u20136.","journal-title":"Stroke"},{"key":"1453_CR15","doi-asserted-by":"crossref","unstructured":"Johnson LSB, Persson AP, Wollmer P, Juul-Moller S, Juhlin T, Engstrom G. Irregularity and lack of p waves in short tachycardia episodes predict atrial fibrillation and ischemic stroke. Heart Rhythm. 2018;15(6):805\u2013811.","DOI":"10.1016\/j.hrthm.2018.02.011"},{"issue":"2","key":"1453_CR16","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/europace\/euw319","volume":"19","author":"J Engdahl","year":"2017","unstructured":"Engdahl J, Svennberg E, Friberg L, Al-Khalili F, Frykman V, Kemp Gudmundsdottir K, Fredriksson T, Rosenqvist M. Stepwise mass screening for atrial fibrillation using N-terminal pro b-type natriuretic peptide: the STROKESTOP II study design. Europace. 2017;19(2):297\u2013302.","journal-title":"Europace"},{"issue":"3","key":"1453_CR17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/14017430802593435","volume":"43","author":"PS Doliwa","year":"2009","unstructured":"Doliwa PS, Frykman V, Rosenqvist M. Short-term ECG for out of hospital detection of silent atrial fibrillation episodes. Scand Cardiovasc J. 2009;43(3):163\u20138.","journal-title":"Scand Cardiovasc J"},{"issue":"9","key":"1453_CR18","first-page":"1449","volume":"19","author":"E Svennberg","year":"2017","unstructured":"Svennberg E, Stridh M, Engdahl J, Al-Khalili F, Friberg L, Frykman V, Rosenqvist M. Safe automatic one-lead electrocardiogram analysis in screening for atrial fibrillation. Europace. 2017;19(9):1449\u201353.","journal-title":"Europace"},{"issue":"11","key":"1453_CR19","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1136\/heartjnl-2018-314186","volume":"105","author":"MH Sejr","year":"2019","unstructured":"Sejr MH, May O, Damgaard D, Sandal BF, Nielsen JC. External continuous ECG versus loop recording for atrial fibrillation detection in patients who had a stroke. Heart. 2019;105(11):848\u201354.","journal-title":"Heart"},{"issue":"1","key":"1453_CR20","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005597","volume":"96","author":"K Suenari","year":"2017","unstructured":"Suenari K, Chao TF, Liu CJ, Kihara Y, Chen TJ, Chen SA. Usefulness of HATCH score in the prediction of new-onset atrial fibrillation for Asians. Medicine. 2017;96(1):e5597.","journal-title":"Medicine"},{"key":"1453_CR21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1471-2261-13-28","volume":"13","author":"M Disertori","year":"2013","unstructured":"Disertori M, Franzosi MG, Barlera S, Cosmi F, Quintarelli S, Favero C, Cappellini G, Fabbri G, Maggioni AP, Staszewsky L, et al. Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: data from the GISSI-AF trial. BMC Cardiovasc Disord. 2013;13:28.","journal-title":"BMC Cardiovasc Disord"},{"issue":"7","key":"1453_CR22","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/j.1540-8167.2012.02341.x","volume":"23","author":"H Kottkamp","year":"2012","unstructured":"Kottkamp H. Fibrotic atrial cardiomyopathy: a specific disease\/syndrome supplying substrates for atrial fibrillation, atrial tachycardia, sinus node disease, AV node disease, and thromboembolic complications. J Cardiovasc Electrophysiol. 2012;23(7):797\u20139.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"5","key":"1453_CR23","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1161\/01.CIR.69.5.1036","volume":"69","author":"PA Boyden","year":"1984","unstructured":"Boyden PA, Tilley LP, Albala A, Liu SK, Fenoglio JJ Jr, Wit AL. Mechanisms for atrial arrhythmias associated with cardiomyopathy: a study of feline hearts with primary myocardial disease. Circulation. 1984;69(5):1036\u201347.","journal-title":"Circulation"},{"issue":"4","key":"1453_CR24","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1161\/01.CIR.96.4.1180","volume":"96","author":"A Frustaci","year":"1997","unstructured":"Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation. 1997;96(4):1180\u20134.","journal-title":"Circulation"},{"key":"1453_CR25","doi-asserted-by":"crossref","unstructured":"Fredriksson T, Frykman V, Friberg L, Al-Khalili F, Engdahl J, Svennberg E. Usefulness of short-lasting episodes of supraventricular arrhythmia (micro-atrial fibrillation) as a risk factor for atrial fibrillation. Am J Cardiol. 2018;122(7):1179\u20131184.","DOI":"10.1016\/j.amjcard.2018.06.030"},{"issue":"24","key":"1453_CR26","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1161\/CIRCULATIONAHA.106.644484","volume":"115","author":"A Jahangir","year":"2007","unstructured":"Jahangir A, Lee V, Friedman PA, Trusty JM, Hodge DO, Kopecky SL, Packer DL, Hammill SC, Shen WK, Gersh BJ. Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study. Circulation. 2007;115(24):3050\u20136.","journal-title":"Circulation"},{"issue":"1","key":"1453_CR27","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1016\/j.hrthm.2014.11.011","volume":"12","author":"DR Van Wagoner","year":"2015","unstructured":"Van Wagoner DR, Piccini JP, Albert CM, Anderson ME, Benjamin EJ, Brundel B, Califf RM, Calkins H, Chen PS, Chiamvimonvat N, et al. Progress toward the prevention and treatment of atrial fibrillation: a summary of the Heart Rhythm Society research forum on the treatment and prevention of atrial fibrillation, Washington, DC, December 9-10, 2013. Heart Rhythm. 2015;12(1):e5\u2013e29.","journal-title":"Heart Rhythm"},{"issue":"9","key":"1453_CR28","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.annepidem.2007.03.013","volume":"17","author":"S Galea","year":"2007","unstructured":"Galea S, Tracy M. Participation rates in epidemiologic studies. Ann Epidemiol. 2007;17(9):643\u201353.","journal-title":"Ann Epidemiol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01453-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-020-01453-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01453-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T19:13:46Z","timestamp":1617995626000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-020-01453-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,10]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1453"],"URL":"https:\/\/doi.org\/10.1186\/s12872-020-01453-w","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,10]]},"assertion":[{"value":"16 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written informed consent was obtained from each patient. The study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki as reflected in a prior approval by the institution\u2019s human research committee. The protocol was approved by the Ethical Review Board in Stockholm, part of the Swedish Ethical Review Authority, with Karolinska Institutet as a host-authority (DNR 2015\/2079\u201331\/1 and 2016\/852\u201332).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication is not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"TF has received unrestricted research grants from Boehringer-Ingelheim & Stiftelsen Hj\u00e4rtat. KKG has received a research grant from Stiftelsen Hj\u00e4rtat. VF has received lecture fees from MSD, Boehringer-Ingelheim, Bayer and Medtronic. LF has received consultancy fees from Bayer, Boehringer-Ingelheim, BMS\/Pfizer and Sanofi. FAK has received lecture fees from Bayer, Boehringer-Ingelheim, and BMS\/Pfizer. JE has received consultancy fees from Pfizer, lecture fees from Bayer, Merck Sharp & Dome, and Medtronic, unrestricted research grants from Pfizer and Boehringer-Ingelheim. ES has received lecture fees from Bayer, Bristol-Myers Squibb-Pfizer, Boehringer- Ingelheim, and Sanofi, as well as unrestricted research grants from Boehringer-Ingelheim, Carl Bennett and Roche.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"167"}}